15 results match your criteria: "Institute for Metabolic Disorders[Affiliation]"
J Diabetes
December 2024
Institute of Epidemiology and Medical Biometry, University of Ulm, Ulm, Germany.
J Diabetes
February 2024
Institute of Epidemiology and Medical Biometry, ZIBMT, University of Ulm, Ulm, Germany.
Aims: Diabetic foot ulcer (DFU) is a leading cause of lower limb amputations in people with diabetes. This study was aimed to retrospectively analyze factors affecting DFU using real-world data from a large, prospective central-European diabetes registry (DPV [Diabetes-Patienten-Verlaufsdokumentation]).
Materials And Methods: We matched adults with type 1 (T1D) or type 2 diabetes (T2D) and DFU to controls without DFU by diabetes type, age, sex, diabetes duration, and treatment year to compare possible risk factors.
Diabet Med
March 2024
Institute of Epidemiology and Medical Biometry, CAQM, University of Ulm, Ulm, Germany.
Aims: To analyse predictors for continuous glucose monitoring (CGM) use in people with diabetes aged ≥60 years using insulin therapy and to assess the rates of CGM use during recent years (2019-2021).
Research Design And Methods: Prospective study including 6849 individuals with diabetes and insulin therapy (type 2 diabetes: n = 5320; type 1 diabetes: n = 1529) aged ≥60 years. Data from 129 treatment centres were retrieved from the Diabetes Prospective Follow-up Registry (DPV) in March 2023.
Ayu
January 2019
Regional Ayurveda Research Institute for Metabolic Disorders, Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Bengaluru, Karnataka, India.
Male factors are responsible for more than forty percent of the infertility cases. Necrozoospermia is one among the main cause for infertility in male. Necrospermia i.
View Article and Find Full Text PDFAnc Sci Life
January 2016
Central Council for Research in Ayurvedic Sciences, Ministry of AYUSH, Government of India, New Delhi, India.
Objective: To establish the pharmacognostic standards for the correct identification and standardization of an important Antidiabetic plant described in Ayurveda.
Materials And Methods: Standardization was carried out on the leaf and stem of L. with the help of the macro-morphological, microscopic, physicochemical and qualitative phytochemical studies.
Diabetes
March 1998
Institute for Metabolic Disorders, Bayer Corporation, West Haven, Connecticut, USA.
Protein-tyrosine phosphatases (PTPases) play an integral role in the regulation of cellular insulin action. LAR, a transmembrane PTPase expressed in insulin-sensitive tissues, acts as a negative regulator of insulin signaling in intact cell models. The physiological role of LAR was studied in mice in which LAR expression was eradicated by insertional mutagenesis.
View Article and Find Full Text PDFBiochem Biophys Res Commun
February 1998
Institute for Metabolic Disorders, Bayer Corporation, West Haven, Connecticut 06516, USA.
Galanin is a peptide hormone which modulates a wide variety of physiological processes, including secretion, muscle contraction, cognitive function, the reproductive axis, and feeding. Two galanin receptor subtypes, GalR1 and GalR2, have been cloned; however, for GalR2 only the rat sequence has been reported in the literature. Our cloning of human GalR2 reveals its amino acid sequence to be 85% identical to rat GalR2 and 39% identical to human GalR1.
View Article and Find Full Text PDFBiochem Biophys Res Commun
February 1997
Institute for Metabolic Disorders, Bayer Corporation, West Haven, Connecticut 06516, USA.
We have used PCR with degenerate oligonucleotide primers to clone novel members of the G protein-coupled receptor (GPCR) superfamily. We report here a novel gene, CEPR, which encodes a candidate receptor that is most similar to the peptide receptor family. The coding region of the human CEPR gene predicts a seven transmembrane domain (TM) receptor of 375 amino acids.
View Article and Find Full Text PDFJ Biol Chem
October 1996
Institute for Metabolic Disorders, Bayer Corporation, West Haven, Connecticut 06516, USA.
Neuropeptide Y (NPY) plays important roles in the central control of appetite and energy balance, but the receptor subtype responsible for this function has not been cloned. Here we report the cloning by expression of a novel NPY receptor subtype from a rat hypothalamus cDNA library. The novel receptor, referred to as the NPY Y5 receptor, has a transcript of approximately 2.
View Article and Find Full Text PDFJ Biol Chem
March 1995
Institute for Metabolic Disorders, Miles, Inc., West Haven, Connecticut 06516, USA.
The binding of glucagon to its hepatic receptor triggers a G-protein-mediated signal that ultimately leads to an increase in hepatic glucose production (gluconeogenesis) and glycogen breakdown (glycogenolysis). In order to elucidate the structural domain(s) of the human glucagon receptor (hGR) involved in the selective binding of glucagon, a series of chimeras was constructed in which various domains of the hGR were replaced by homologous regions from the receptor for the glucoincretin hormone, glucagon-like peptide I (GLP-IR). hGR and GLP-IR are quite similar (47% amino acid identify) yet have readily distinguishable ligand binding characteristics; glucagon binds to the recombinant hGR expressed in COS-7 cells with a Kd that is 1000-fold lower than the Kd for glucagon binding to GLP-IR.
View Article and Find Full Text PDFJ Clin Invest
January 1995
Institute for Metabolic Disorders, Miles Inc., West Haven, Connecticut 06516.
The effect of increased Glut4 protein expression in muscle and fat on the whole body glucose metabolism has been evaluated by the euglycemic hyperinsulinemic clamp technique in conscious mice. Fed and fasting plasma glucose concentrations were 172 +/- 7 and 78 +/- 7 mg/dl, respectively, in transgenic mice, and were significantly lower than that of nontransgenic littermates (208 +/- 5 mg/dl in fed; 102 +/- 5 mg/dl in fasting state). Plasma lactate concentrations were higher in transgenic mice, (6.
View Article and Find Full Text PDFBiochem Biophys Res Commun
November 1994
Institute for Metabolic Disorders, Miles, Inc., West Haven, CT 06516.
This report describes the isolation of a cDNA for the rat glucagon receptor by using the glucagon-like peptide 1 receptor cDNA as a probe. Northern blot analysis using the cDNA clone showed that the message encoding the receptor is approximately 2.3 kb in size and is expressed only in liver and kidney among seven tissues tested.
View Article and Find Full Text PDFJ Immunol
March 1994
Institute for Metabolic Disorders, Miles Research Center, West Haven, CT 06516.
Islet cell Ag 512 (ICA512) is a recombinant human Ag that was isolated from an islet cDNA expression library by screening with human insulin-dependent diabetes mellitus sera. Specificity of reaction with diabetic sera was demonstrated initially by immunoprecipitation with a small number of diabetic and normal serum samples. To permit quantitative and rapid serum testing, ICA512 was purified and adapted to an ELISA format.
View Article and Find Full Text PDFBiochem Biophys Res Commun
August 1993
Institute for Metabolic Disorders, Miles Research Center, West Haven, CT 06516.
J Exp Zool
May 1993
Institute for Metabolic Disorders, Miles Research Center, West Haven, Connecticut 06516.
Seminal vesicle proteins (SVPs) are made by male rodents, and form the copulatory plug following mating. Here we report a partial nucleotide sequence of a mouse clone homologous to rat SVP F. Unexpectedly, we found that SVP F-related transcripts are expressed at high levels in mouse skeletal muscle.
View Article and Find Full Text PDF